Woodline Partners »

Reviva Pharmaceutcls Hldgs I shares owned by Woodline Partners

Quarter-by-quarter ownership of Reviva Pharmaceutcls Hldgs I (RVPH) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Reviva Pharmaceutcls Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceutcls Hldgs I held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceutcls Hldgs I by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.0M 1.1M 3.78

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Te Connectivity SHS (TEL)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Analog Devices (ADI)
Avnet (AVT)
Merck & Co (MRK)
Revolution Medicines (RVMD)
Zimmer Holdings (ZBH)
Meta Platforms Cl A (META)
Roivant Sciences SHS (ROIV)
Abbvie (ABBV)
Enerplus Corp (ERF)
Permian Resources Corp Class A Com (PR)
Amazon (AMZN)

View all positions for Woodline Partners

Top funds holding Reviva Pharmaceutcls Hldgs I

Woodline Partners
Vanguard Group
Millennium Management
Schonfeld Strategic Advisors
Parkman Healthcare Partners
Susquehanna International
Geode Capital Management
Colony
Citadel Advisors
Polar Securities
EMC Capital Management
BlackRock
Northern Trust
Jpmorgan Chase & Co
Marshall Wace

View all funds holding Reviva Pharmaceutcls Hldgs I